Lee Ainslie - Maverick Capital
Holding/activity history for Regeneron Pharmaceuticals, Inc. (REGN)
← All REGN superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2024 Q1 | 0 | 0.00 | Sell 100.00% | 0.03 | $871.39–998.33 · VW $949.58i | SEC | |
| 2023 Q4 | 1,758 | 0.03 | Buy | 0.03 | $769.19–899.86 · VW $828.27i | $1,544,034 | SEC |
| 2021 Q4 | 0 | 0.00 | Sell 100.00% | <0.01 | $539.18–673.86 · VW $623.61i | SEC | |
| 2021 Q3 | 490 | <0.01 | Buy | <0.01 | $554.95–686.62 · VW $620.34i | $297,000 | SEC |
| 2020 Q4 | 0 | 0.00 | Sell 100.00% | 0.01 | $470.78–619.97 · VW $535.39i | SEC | |
| 2020 Q3 | 588 | 0.01 | Buy | 0.01 | $540.00–664.64 · VW $607.58i | $329,000 | SEC |
Price snapshot:
Current price$663.09
52-week low$538.55
52-week high$818.90